COVID-19 and thromboembolic disease


Accueil Synopsis programme Test CME
COVID-19 and thromboembolic disease 09 July 2021 12. COVID-19, 1-hour Oral Session • S56 • 08:30 > 09:30 • COVID-19 and thromboembolic disease • 12. COVID-19 08:30 • 3161 • Thrombosis pathways in COVID-19 versus influenza-associated acute respiratory distress syndrome (ARDS): a targeted proteomics approach > E. Emma RADEMAKER (Utrecht) 08:40 • 2857 • Venous thromboembolic disease and D-dimer in non-critically ill patients with COVID-19 pneumonia > J. Júlia SELLARÈS-NADAL (Barcelona) 08:50 • 989 • Increased incidence of secondary infections in COVID-19 patients with thrombotic complications > M. Marco RIPA (Milano) 09:00 • 1038 • Early treatment with low-molecular-weight heparin reduces mortality rate of SARS-CoV-2 patients > A. Andrea DE VITO (Sassari) 09:10 • INT16 • Q&A/Discussion